T. he Food and Drug Administration on Wednesday approved a promising new treatment for a particularly deadly form of cancer, bringing hope to desperate patients while rekindling a global conversation about the escalating cost of new therapies.
The treatment, made by Gilead Sciences, is made by extracting patients’ white blood cells and re-engineering them to home in on tumors. Called a CAR-T, the one-time treatment has shown unprecedented results for patients with dire diagnoses. This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today.
It’s easy! Your first 30 days are free and if you don’t enjoy your subscription you can cancel any time.